Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2006-08-29
2006-08-29
Saeed, Kamal A. (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C548S504000
Reexamination Certificate
active
07098233
ABSTRACT:
Compounds of Formula (I): (I); wherein: R1and R2either the same or different, are H or linear or branched C1–C6alkyl; R3=linear or branched C1–C6alkyl; R4=halogen, and pharmaceutically acceptable salts thereof are useful as active ingredients in the preparation of medicaments used as ligands of the 5-HT6and/or 5-HT7serotoninergic receptors.
REFERENCES:
patent: 2825734 (1958-03-01), Speeter
patent: 4138489 (1979-02-01), Thal et al.
patent: 4428877 (1984-01-01), Szantay et al.
patent: 4980368 (1990-12-01), Thielke et al.
patent: 5300645 (1994-04-01), Audia et al.
patent: 5504101 (1996-04-01), Glennon
patent: 5688807 (1997-11-01), Audia et al.
patent: 5726177 (1998-03-01), Halazy et al.
patent: 6403808 (2002-06-01), Glennon et al.
patent: 0 937 715 (1999-08-01), None
patent: 00/34242 (2000-06-01), None
patent: 00/63203 (2000-10-01), None
patent: 01/12629 (2001-02-01), None
patent: WO 2004041781 (2004-05-01), None
Glennon, R., et al., “2-Substituted Tryptamines: Agents with Selectivity for 5-HT6 Serotonin Receptors,”J. Med. Chem., vol. 43(5), pp. 1011-1018 (Mar. 2000), at p. 1012, Scheme 1; p. 1013, Table 1 (compound 8, “EMDT”); & p. 1014, Table 2 (5HT7 and 5HT6).
Spadoni, G., et al., “2-Substituted 5-Methyoxy-N-acyltryptamines: Synthesis, Binding Affinity for the Melatonin Receptor, and Evaluation of the Biological Activity,” J. Med. Chem., vol. 36(25), pp. 4069-4074 (Dec. 1993) at p. 4070, col. 1, Scheme 1.
Branchek, T., “5-HT6 Receptors as Emerging Targets for Drug Discovery,” Ann. Rev. Pharm. Tox., vol. 40, pp. 319-334 (2000), at Abstract; p. 322, line 40 to p. 323, line 3; and p. 328, lines 11-30.
Worthen, D., et al., “Endogenous indoles as novel polyamine site ligands at the N-methyl-D-aspartate receptor complex,” Brian Research, vol. 890(2), pp. 343-346 (Feb. 2, 2001), at p. 344, Table 1; also p. 343, lines 6-8.
Russell, M., and Dias, R., “Memories are Made of this (Perhaps): A Review of Serotonin 5-HT6 Receptor Ligands and Their Biological Functions,” Curr. Top. Med. Chem., vol. 2(6), pp. 643-654 (Jun. 2002), at p. 645, col. 1, lines 22-29 and Figure 1.
Glennon, R., “Higher-End Serotonin Receptors: 5-HT5, 5-HT6 and 5-HT7,” J. Med. Chem., vol. 46(14), pp. 2795-2812 (Jul. 3, 2003), at p. 2795, col. 2, lines 14-22.
Schmitz, D., et al., “Serotonin reduces synaptic excitation in the superficial medial entorhinal cortex of the rat via a presynaptic mechanism,” J. Physiology, vol. 508 (Pt 1), pp. 119-129 (Apr. 1998), at p. 119, col. 2, lines 2-6; p. 120, lines 40-41.
Gungor, T., et al., “N6-substituted Adenosine Receptor Agonists. Synthesis and Pharmacological Activity as Potent Antinociceptive Agents,” J. Med. Chem., vol. 37(25), pp. 4307-4316 (1994), at p. 4310, Table 2 (cmpds 15b and 6b).
Benington, F., et al., “Synthesis of Some 5- and 6-Chloro, 5-Methyl, and 5,6,7-Trimethyl Derivatives of Tryptamine,” J. Org. Chem., vol. 25(9), pp. 1542-1547 (Sep. 1960), at p. 1543, Chart I (“compound VIII”); p. 1545, col. 2, lines 61-72.
Lee et al; “5-HT6 Serotonin Receptor Binding Affinities of N1-Benzenesulfonyl and Related Tryptamines”; Medicinal Chemistry Reserch, Birkhaeuser, Boston, US, vol. 4, No. 10, 2000, pp. 230-242, XP001079522.
Chapman et al; “5-Substituted-2-Methyltryptamines and Their N-Mono-and N,N-Dialkyl Derivatives” J. Chem. Soc., Feb. 1965, pp. 1424-1428, XP00109902.
Di Cesare Maria Assunta
Minetti Patrizia
Spadoni Gilberto
Tarzia Giorgio
Saeed Kamal A.
Sigma-Tau Industrie Farmaceutiche Riunite S.p.A.
LandOfFree
5-halo-tryptamine derivatives used as ligands on the 5-HT 6... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 5-halo-tryptamine derivatives used as ligands on the 5-HT 6..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 5-halo-tryptamine derivatives used as ligands on the 5-HT 6... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3661771